Congressman Reveals Depression Battle, VNS Therapy Explored

Major depressive disorder (MDD) is a debilitating medical illness impacting mood, thinking, sleep, and energy for at least two weeks, significantly interfering with daily life. Unlike normal sadness, MDD affects the entire nervous system and is a leading cause of global disability. While medication, lifestyle changes, and psychotherapy are standard treatments, researchers are exploring novel approaches like vagus nerve stimulation (VNS).

VNS involves sending low-level electrical impulses to the vagus nerve via an implanted device or non-invasive methods. This nerve regulates crucial bodily functions, including heart rate, breathing, and stress hormone release. A recent study indicated that surgically implanted VNS led to meaningful depression symptom improvements in over 43% of participants with treatment-resistant depression.

Surgical VNS is an option for severe, chronic depression unresponsive to other treatments, though costs can exceed $30,000-$50,000 without insurance. Non-invasive VNS devices are available for those seeking lower-risk options. Experts suggest trying an over-the-counter VNS device for 12 weeks, followed by professional evaluation for persistent symptoms or consideration of surgical VNS.

Emerging treatments like VNS offer new hope for individuals living with major depressive disorder. Consulting with a healthcare professional is crucial to determine if VNS is a suitable option for managing depression symptoms and improving overall well-being.